|
N-nitrososarcosine limit
|
|
5
|
691
|
May 23, 2024
|
|
Acceptable intake (AI) of N-Nitroso-N-methylbenzylamine (CAS 937-40-6)
|
|
4
|
455
|
May 21, 2024
|
|
Category 5 NDSRIs- CPCA tool
|
|
2
|
523
|
May 20, 2024
|
|
Hot of the presses - New CPCA paper
|
|
1
|
427
|
May 17, 2024
|
|
Nitrosamine AI limit calculation if the risk is coming only out of excipients'
|
|
11
|
1202
|
May 13, 2024
|
|
N-Nitroso Metformin
|
|
8
|
1722
|
January 29, 2024
|
|
Nitrosamines Published Limits -reference
|
|
79
|
16544
|
May 10, 2024
|
|
NDSRI Limit of those product's having lower MDD
|
|
1
|
574
|
May 6, 2024
|
|
N-nitroso acyclovir impurity K
|
|
1
|
546
|
April 30, 2024
|
|
🇺🇸 FDA NDSRI Limits update -Mar 2024
|
|
6
|
2251
|
April 22, 2024
|
|
Limit for Nitroso Ciprofloxacin
|
|
24
|
4050
|
April 22, 2024
|
|
Nitrosamine testing results
|
|
9
|
979
|
April 18, 2024
|
|
Whether N-Nitroso Memantine is possible?
|
|
16
|
1085
|
April 10, 2024
|
|
Acrostic - facilitating, supporting and documenting read-across!
|
|
4
|
703
|
April 8, 2024
|
|
N-Nitroso Edoxaban Desmethyl Impurity CPCA Score
|
|
6
|
1316
|
April 8, 2024
|
|
Request for risk assessment and confirmatory testing for nortriptyline containing products
|
|
4
|
652
|
April 3, 2024
|
|
AI Limit for Nitroso Nebivolol
|
|
11
|
2759
|
April 3, 2024
|
|
AI difference between FDA and EMA, HC and TGA
|
|
0
|
1156
|
March 22, 2024
|
|
IVACAFTOR (N-Nitroso Ivacaftor)
|
|
0
|
364
|
March 22, 2024
|
|
Calculating Nitrosamine Limits (MasterClass)
|
|
4
|
1981
|
March 19, 2024
|
|
N-nitroso cyclamate
|
|
9
|
713
|
March 15, 2024
|
|
NDMA evaluation in battery of in vivo Genotoxicity assays once again leading to AI much greater than 96 ng/day
|
|
0
|
322
|
March 13, 2024
|
|
Open-Access Software for Chemical Read-Across
|
|
0
|
394
|
March 12, 2024
|
|
LOQ for small nitrosamines
|
|
1
|
443
|
March 11, 2024
|
|
AI limit for N-Nitroso Losartan
|
|
4
|
675
|
March 9, 2024
|
|
Ribociclib Succinate NDSRIs limit clarification related
|
|
6
|
1046
|
March 5, 2024
|
|
AI value for Nitroso Folic acid
|
|
4
|
1769
|
February 26, 2024
|
|
Risk characterization of N-nitrosodimethylamine in pharmaceuticals -Pub
|
|
6
|
695
|
February 16, 2024
|
|
Developing and validating read-across workflows that enable decision making for toxicity and potency: Case studies with N-nitrosamines -Pub
|
|
4
|
465
|
February 14, 2024
|
|
Nitrosamines Severity (impact) - a quantitative model proposal?
|
|
3
|
1016
|
February 12, 2024
|